Showing 1,481 - 1,500 results of 1,890 for search '"type II diabetes"', query time: 0.15s Refine Results
  1. 1481

    Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy? by Anna R. Carta, Augusta Pisanu, Ezio Carboni

    Published 2011-01-01
    “…Thiazolidinediones (TZDs) are peroxisome proliferator-activated receptor (PPAR)-γ agonists commonly used as insulin-sensitizing drugs for the treatment of type 2 diabetes. In the last decade, PPAR-γ agonists have received increasing attention for their neuroprotective properties displayed in a variety of neurodegenerative diseases, including Parkinson's disease (PD), likely related to the anti-infammatory activity of these compounds. …”
    Get full text
    Article
  2. 1482

    Visfatin/Nampt: An Adipokine with Cardiovascular Impact by Tania Romacho, Carlos F. Sánchez-Ferrer, Concepción Peiró

    Published 2013-01-01
    “…Enhanced circulating visfatin/Nampt levels have been reported in metabolic diseases, such as obesity and type 2 diabetes. Moreover, visfatin/Nampt circulating levels correlate with markers of systemic inflammation. …”
    Get full text
    Article
  3. 1483

    Insulin Therapy in Diabetic Hyperglycemic Emergencies by Diana Machado Ramírez, Manuel Licea Puig

    Published 2014-09-01
    “…<br /><strong>Results:</strong> diabetic ketoacidosis occurred in 57.5 % of the type 1 diabetic patients and in the 42.5 % of the type 2 diabetics. None of the type 1 diabetics developed hyperglycemic hyperosmolar nonketotic state and this complication was observed in 23.0 % of the patients with diabetes type 2. …”
    Get full text
    Article
  4. 1484

    Evaluating the Effect of Ramadan Fasting on Muslim Patients with Diabetes in relation to Use of Medication and Lifestyle Patterns: A Prospective Study by Melanie Yee Lee Siaw, Daniel Ek Kwang Chew, Rinkoo Dalan, Shaikh Abdul Kader Kamaldeen Abdul Shakoor, Noorani Othman, Chor Hui Choo, Nur Hidayah Shamsuri, Siti Nurhana Abdul Karim, Sui Yung Chan, Joyce Yu-Chia Lee

    Published 2014-01-01
    “…This study aimed to examine the effect of Ramadan fasting on HbA1c in Muslim patients with type 2 diabetes. The incidence of hypoglycemia and glycemic changes in relation to the adjustment of doses of antidiabetic agents, diet, and physical activity during Ramadan was also evaluated. …”
    Get full text
    Article
  5. 1485

    Genome-Wide DNA Methylation in Mixed Ancestry Individuals with Diabetes and Prediabetes from South Africa by Tandi E. Matsha, Carmen Pheiffer, Stephen E. Humphries, Junaid Gamieldien, Rajiv T. Erasmus, Andre P. Kengne

    Published 2016-01-01
    “…To conduct a genome-wide DNA methylation in individuals with type 2 diabetes, individuals with prediabetes, and control mixed ancestry individuals from South Africa. …”
    Get full text
    Article
  6. 1486

    Metformin Inhibits Mouse Islet Insulin Secretion and Alters Intracellular Calcium in a Concentration-Dependent and Duration-Dependent Manner near the Circulating Range by Lindor Gelin, Jiewen Li, Kathryn L. Corbin, Ishrat Jahan, Craig S. Nunemaker

    Published 2018-01-01
    “…Metformin is considered the first-line treatment for type 2 diabetes. While metformin primarily increases insulin sensitivity, evidence also suggests that metformin affects the activity of insulin-secreting pancreatic islets. …”
    Get full text
    Article
  7. 1487

    Mechanistic insights toward progress in alogliptin beyond glycemic control: translational perspective by Faraha Ahmed, Syed Sufian Ahmad, M. Mumtaz Alam, M. Shaqiquzzaman, Abul Kalam Najmi, Mohammad Ahmed Khan

    Published 2025-02-01
    “…Main body Alogliptin is approved for treatment of type 2 diabetes mellitus (T2DM) in majority of the countries. …”
    Get full text
    Article
  8. 1488

    Engaging with patients with diabetes: the role of social media in low-income healthcare organisations by Jose Rodriguez, Shabbir Syed-Abdul, Andrea Cano, Mohy Uddin, Fernanda Caceres

    Published 2025-02-01
    “…Background Type 2 diabetes is the fastest-growing global health concern, and its global prevalence is projected to affect 643 million individuals by 2030. …”
    Get full text
    Article
  9. 1489

    Diabetes mellitus educational intervention in patients at risk from a medical office. Nuevitas, 2020-2023 by Maigret Calderón Cruz, Julio Michel Arias Manganelly, Olenis Alicia Aldana Ramos, Lieter Ailed Vidal Rodríguez, Pedro Figueredo Guerra, Aned Hernández Clavijo

    Published 2024-05-01
    “…<br /><strong>Objective</strong>: to describe an educational intervention on type 2 diabetes mellitus results in patients with risk factors.…”
    Get full text
    Article
  10. 1490

    Infant of a diabetic mother: clinical presentation, diagnosis and treatment by Magdalena Suda-Całus, Katarzyna Dąbrowska, Ewa Gulczyńska

    Published 2024-04-01
    “…Rising incidence of type 1 and type 2 diabetes in young women and increasing maternal age at conception account for the higher risk of birth complications and adverse maternal and infant outcomes. …”
    Get full text
    Article
  11. 1491

    In Vivo and Ex Vivo Evaluation of 1,3-Thiazolidine-2,4-Dione Derivatives as Euglycemic Agents by Diana Alemán-González-Duhart, Samuel Álvarez-Almazán, Miguel Valdes, Feliciano Tamay-Cach, Jessica Elena Mendieta-Wejebe

    Published 2021-01-01
    “…Thiazolidinediones (TZDs), used to treat type 2 diabetes mellitus, act as full agonists of the peroxisome proliferator-activated receptor gamma. …”
    Get full text
    Article
  12. 1492

    Diabetic Retinopathy Screening Ratio Is Improved When Using a Digital, Nonmydriatic Fundus Camera Onsite in a Diabetes Outpatient Clinic by Pia Roser, Hannes Kalscheuer, Jan B. Groener, Daniel Lehnhoff, Roman Klein, Gerd U. Auffarth, Peter P. Nawroth, Florian Schuett, Gottfried Rudofsky

    Published 2016-01-01
    “…This cross-sectional study included 502 patients, 112 with type 1 and 390 with type 2 diabetes. Patients attended screenings for microvascular complications, including diabetic nephropathy (DN), diabetic polyneuropathy (DP), and DR. …”
    Get full text
    Article
  13. 1493

    Charge-Based Inhibitors of Amylin Fibrillization and Toxicity by Sharadrao M. Patil, Andrei T. Alexandrescu

    Published 2015-01-01
    “…To test the hypothesis that electrostatic repulsion is an important force opposing amyloid fibril assembly, we designed peptides that substitute strings of positively or negatively charged residues into the sequence of the amyloidogenic hormone amylin, which contributes to type 2 diabetes pathology. Arg-1 and Arg-2 substitute four positively charged arginines for segments that in structural models of amylin fibrils form the end of strand β1 and the beginning of strand β2, respectively. …”
    Get full text
    Article
  14. 1494

    Review of Finger millet (Eleusine coracana (L.) Gaertn): A power house of health benefiting nutrients by Dinesh Chandra, Satish Chandra, Pallavi, A.K. Sharma

    Published 2016-09-01
    “…It has distinguished health beneficial properties, such as anti-diabetic (type 2 diabetes mellitus), anti-diarrheal, antiulcer, anti-inflammatory, antitumerogenic (K562 chronic myeloid leukemia), atherosclerogenic effects, antimicrobial and antioxidant properties.…”
    Get full text
    Article
  15. 1495

    Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human Diabetes by Anna Weiser, Pieter Giesbertz, Hannelore Daniel, Britta Spanier

    Published 2018-01-01
    “…The New Zealand obese (NZO) mouse is a polygenic model for obesity and diabetes with obese females and obese, diabetes-prone males, used to study traits of the metabolic syndrome like type 2 diabetes mellitus (T2DM), obesity, and dyslipidaemia. …”
    Get full text
    Article
  16. 1496

    Diabetes Risk Score in a Young Student Population in Jordan: A Cross-Sectional Study by Abdel-Ellah Al-Shudifat, Amjad Al-Shdaifat, Ahmad Ali Al-Abdouh, Mohammad Ibrahim Aburoman, Sara Mohammad Otoum, Amro Ghaleb Sweedan, Ibrahim Khrais, Ibrahim Hisham Abdel-Hafez, Asgeir Johannessen

    Published 2017-01-01
    “…The Middle East is the home to the most obese population in the world, and type 2 diabetes mellitus is endemic in the region. However, little is known about risk factors for diabetes in the younger age groups. …”
    Get full text
    Article
  17. 1497

    Performance Comparison of Two Gene Set Analysis Methods for Genome-wide Association Study Results: GSA-SNP vs i-GSEA4GWAS by Ji-sun Kwon, Jihye Kim, Dougu Nam, Sangsoo Kim

    Published 2012-06-01
    “…GSA runs were made with two sets of p-values from a Korean type 2 diabetes mellitus GWAS study: 259,188 and 1,152,947 SNPs of the original and imputed genotype datasets, respectively. …”
    Get full text
    Article
  18. 1498

    What patients with diabetes mellitus type 2 know on their disease by Belkis Mercedes Vicente Sánchez, Gisela Zerquera Trujillo, Elodia M. Rivas Alpizar, José A. Muñoz Cocina, Yaremy Teresita Gutiérrez Cantero, Eduardo Castañedo Álvarez

    Published 2010-12-01
    “…<strong><br />Objective:</strong> to determine how much patients with type 2 diabetes know about the disease. <br /><strong>Methods:</strong> descriptive study of a case series conducted between January and June 2008. …”
    Get full text
    Article
  19. 1499

    Comparison of Insulin Lispro Protamine Suspension with NPH Insulin in Pregnant Women with Type 2 and Gestational Diabetes Mellitus: Maternal and Perinatal Outcomes by Antonietta Colatrella, Natalia Visalli, Santina Abbruzzese, Sergio Leotta, Marzia Bongiovanni, Angela Napoli

    Published 2013-01-01
    “…Eighty-nine pregnant women (25 with type 2 diabetes and 64 with gestational diabetes mellitus; 53 under insulin lispro protamine suspension and 36 under human NPH insulin) were recruited. …”
    Get full text
    Article
  20. 1500

    Functional Stability of Plasminogen Activator Inhibitor-1 by Songul Yasar Yildiz, Pinar Kuru, Ebru Toksoy Oner, Mehmet Agirbasli

    Published 2014-01-01
    “…The biological effects of PAI-1 extend far beyond thrombosis including its critical role in fibrotic disorders, atherosclerosis, renal and pulmonary fibrosis, type-2 diabetes, and cancer. The conversion of PAI-1 from the active to the latent conformation appears to be unique among serpins in that it occurs spontaneously at a relatively rapid rate. …”
    Get full text
    Article